XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE-BASED COMPENSATION (Tables)
 12 Months Ended
Oct. 31, 2022
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three most recent fiscal years.


   
Year Ended
  
   
October 31,
2022
    
October 31,
2021
    
October 31,
2020
  
Expense reported in:
                  
     Cost of goods sold
  
$
868
    
$
446
    
$
337
  
     Selling, general and administrative
    
4,803
      
4,446
      
4,590
  
     Research and development
    
637
      
456
      
-
  
Total expense incurred
  
$
6,308
    
$
5,348
    
$
4,927
  
                         
Expense by award type:
    
                 
Restricted stock awards
   $
 5,800     $
 4,920     $
 4,140  
Stock options
     298       218       649  
Employee stock purchase plan
     210       210       138  
Total expense incurred
   $
 6,308
     $
 5,348
     $
 4,927
  
                         
Income tax benefits of share-based compensation
  
$
449
    
$
233
    
$
168
  
Share-based compensation cost capitalized
  
$
-
    
$
-
    
$
-
  
Restricted Stock Awards Activity A summary of restricted stock award activity during 2022 and the status of our restricted stock awards as of October 31, 2022, is presented below.

Restricted Stock
  
Shares
    
Weighted-Average
Fair Value at
Grant Date
  
             
Outstanding at October 31, 2021
    
929,147
    
$
12.08
  
Granted
    
654,224
    
$
18.73
  
Vested
    
(407,716
)
  
$
12.78
  
Cancelled
    
(281,951
)
  
$
15.27
  
Outstanding at October 31, 2022
    
893,704
    
$
15.62
  
Expected to vest as of October 31, 2022
    
814,294
    
$
15.52
  
Additional Information on Restricted Stock Awards

The table below presents additional information on our restricted stock awards for the three most recent fiscal years.


   
Year Ended
  
   
October 31,
2022
    
October 31,
2021
    
October 31,
2020
  
                   
Number of shares granted
    
654,224
      
564,800
      
538,000
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
18.73
    
$
11.20
    
$
15.08
  
Compensation costs not yet recognized
   $
8,949     $
 7,300     $
 6,933  
Weighted-average amortization period (in years)
     2.7       2.6       2.8  
Fair value of awards for which restrictions lapsed
  
$
5,212
    
$
4,491
    
$
2,957
  
Shares outstanding at balance sheet date
     893,704       929,147
       812,316
  
Stock Options Activity

The table below presents a summary of stock options activity during 2022 and information on stock options outstanding at October 31, 2022.

 
Shares
    
Weighted-Average
Exercise Price
  
Weighted-Average
Remaining
Contractual Life
  
Aggregate
Intrinsic Value
  
                         
Outstanding at October 31, 2021
    
1,173,103
    
$
9.49
          
Granted
    
-
     $
-
          
Exercised
    
(571,514
)
  
$
9.23
          
Cancellations, forfeitures, and adjustments
    
12,412

 
$
9.74
          
Outstanding at October 31, 2022
    
614,001
    
$
9.74
  
3.3 years
  
$
3,980
  
Exercisable at October 31, 2022
    
590,275
    
$
9.74
  
3.2 years
  
$
3,827
  
Expected to vest as of October 31, 2022
    
23,559
    
$
9.78
  
6.2 years
  
$
152
  
Additional Information on Stock Option Awards

The table below presents additional information on stock option awards for the three most recent fiscal years.


   
Year Ended
  
   
October 31,
2022
    
October 31,
2021
    
October 31,
2020
  
                   
Number of options granted in period
     -
       -
       -
  
Total intrinsic value of options exercised
  
$
5,108
    
$
1,910
    
$
3,184
  
Cash received from option exercises
  
$
5,275
    
$
3,441
    
$
3,746
  
Compensation cost not yet recognized
   $
 13     $
 109     $
 378  
Weighted-average amortization period for cost not yet recognized (in years)
     0.2       1.1       1.7